Brokerage firm Mizuho Securities Upgrades its rating on Allergan plc Ordinary Shares(NYSE:AGN). The shares have been rated Buy. Previously, the analysts had a Neutral rating on the shares. The rating by Mizuho Securities was issued on Aug 19, 2016.
In a different note, On Aug 9, 2016, Deutsche Bank said it Maintains its rating on Allergan plc Ordinary Shares. In the research note, the firm Lowers the price-target to $282.00 per share. The shares have been rated ‘Buy’ by the firm. Credit Suisse said it Initiates Coverage on Allergan plc Ordinary Shares, according to a research note issued on Jul 25, 2016. The shares have been rated ‘Outperform’ by the firm.
Allergan plc Ordinary Shares (AGN) shares turned negative on Mondays trading session with the shares closing down -1.28 points or -0.54% at a volume of 28,69,077. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $238.7899. The peak price level was also seen at $238.7899 while the days lowest was $235.14. Finally the shares closed at $236.65. The 52-week high of the shares is $322.68 while the 52-week low is $195.5. According to the latest information available, the market cap of the company is $93,702 M.
Allergan plc Ordinary Shares(AGN) last announced its earnings results on Aug 8, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $3.69B. Analysts had an estimated revenue of $4.11B. Earnings per share were $3.35. Analysts had estimated an EPS of $3.35.
Several Insider Transactions has been reported to the SEC. On Aug 9, 2016, Nesli Basgoz (director) sold 758 shares at $253.02 per share price.Also, On Jun 6, 2016, Maria Teresa Hilado (CFO) purchased 661 shares at $241.57 per share price.On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price, according to the Form-4 filing with the securities and exchange commission.